Oviva
Z├╝rich
About Oviva
Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform. They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allows patients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions. Oviva was founded in 2013 and is based in Altendorf (Switzerland) with offices in Zurich (Switzerland), London (United Kingdom), and Berlin (Germany).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $10K – $50K
- Total funding: $346.7M
- Funding stage: Late Stage Venture
- Last round: Secondary Market (Jan 2026)
- Website: oviva.com
- Phone: +44 2076330777
Industries & Categories
Consulting, Health Care, Medical, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/oviva-25674 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.